HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haemophilus influenzae type b: the search for a vaccine.

Abstract
In adults Hib CPS protein conjugates are much more immunogenic than the polysaccharide alone; further studies have shown that they induce a booster response in children. The antibodies produced in response to the conjugates have the same biologic properties, isotype and IgG subclass composition as those elicited by Hib CPS alone or those present in serum after convalescence from Hib disease. More recently attempts have been made to make the conjugates compatible with DTP vaccine. In this procedure DTP is absorbed onto aluminum compounds (aluminum hydroxide or phosphate), with the effect of significantly prolonging diphtheria and tetanus antibody synthesis. Adsorption of the Hib CPS conjugate under controlled conditions does not alter the total amount of antibody elicited in infant rhesus monkeys after the third or final injection. The appearance of Hib CPS antibodies after the first injection, however, is accelerated with conjugate that has been adsorbed. This is an encouraging finding, because it means that more polysaccharide conjugates can be compatible with existing DTP vaccine.
AuthorsJ B Robbins, R Schneerson
JournalThe Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 6 Issue 8 Pg. 791-4 (Aug 1987) ISSN: 0891-3668 [Print] United States
PMID3313243 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Haemophilus Vaccines
  • Haemophilus influenzae type b polysaccharide vaccine
  • Polysaccharides, Bacterial
Topics
  • Antibodies, Bacterial (biosynthesis)
  • Bacterial Capsules
  • Bacterial Vaccines
  • Child, Preschool
  • Haemophilus Infections (prevention & control)
  • Haemophilus Vaccines
  • Haemophilus influenzae (immunology)
  • Humans
  • Infant
  • Meningitis, Haemophilus (prevention & control)
  • Polysaccharides, Bacterial (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: